Healthcare provider profile · identity verified

Emily Rothman, DO

Family Practice · ALBUQUERQUE, NM · NPI 1124119698

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	949	176
Atorvastatin Calcium	Atorvastatin Calcium	671	172
Gabapentin	Gabapentin	667	178
Eliquis	Apixaban	621	107
Lisinopril	Lisinopril	413	106
Furosemide	Furosemide	394	102
Amlodipine Besylate	Amlodipine Besylate	375	108
Tamsulosin Hcl	Tamsulosin Hcl	349	95
Potassium Chloride	Potassium Chloride	304	67
Trazodone Hcl	Trazodone Hcl	302	96
Metoprolol Succinate	Metoprolol Succinate	295	73
Famotidine	Famotidine	285	70
Pantoprazole Sodium	Pantoprazole Sodium	280	105
Losartan Potassium	Losartan Potassium	253	71
Escitalopram Oxalate	Escitalopram Oxalate	249	55
Mirtazapine	Mirtazapine	218	57
Metoprolol Tartrate	Metoprolol Tartrate	208	62
Xarelto	Rivaroxaban	208	39
Memantine Hcl	Memantine Hcl	203	44
Finasteride	Finasteride	202	43
Levetiracetam	Levetiracetam	201	45
Metformin Hcl	Metformin Hcl	197	49
Sertraline Hcl	Sertraline Hcl	194	47
Duloxetine Hcl	Duloxetine Hcl	183	57
Donepezil Hcl	Donepezil Hcl	173	38
Carvedilol	Carvedilol	156	54
Baclofen	Baclofen	154	38
Clopidogrel	Clopidogrel Bisulfate	132	34
Spironolactone	Spironolactone	132	30
Buspirone Hcl	Buspirone Hcl	124	35
Divalproex Sodium	Divalproex Sodium	112	27
Citalopram Hbr	Citalopram Hydrobromide	99	29
Hydroxyzine Hcl	Hydroxyzine Hcl	93	39
Ropinirole Hcl	Ropinirole Hcl	90	16
Latanoprost	Latanoprost	87	18
Quetiapine Fumarate	Quetiapine Fumarate	87	30
Hydralazine Hcl	Hydralazine Hcl	85	29
Prazosin Hcl	Prazosin Hcl	83	16
Simvastatin	Simvastatin	83	20
Allopurinol	Allopurinol	82	19
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	80	31
Montelukast Sodium	Montelukast Sodium	75	24
Fluticasone Propionate	Fluticasone Propionate	74	39
Fluoxetine Hcl	Fluoxetine Hcl	72	18
Prednisone	Prednisone	71	27
Bupropion Xl	Bupropion Hcl	70	19
Omeprazole	Omeprazole	69	24
Tizanidine Hcl	Tizanidine Hcl	68	19
Aripiprazole	Aripiprazole	66	16
Carbidopa-Levodopa	Carbidopa/Levodopa	64	18
Venlafaxine Hcl Er	Venlafaxine Hcl	63	17
Oxybutynin Chloride	Oxybutynin Chloride	58	15
Olanzapine	Olanzapine	56	16
Oxybutynin Chloride Er	Oxybutynin Chloride	56	11
Diclofenac Sodium	Diclofenac Sodium	53	22
Pravastatin Sodium	Pravastatin Sodium	53	12
Amiodarone Hcl	Amiodarone Hcl	50	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	49	23
Ondansetron Hcl	Ondansetron Hcl	48	34
Risperidone	Risperidone	47	19
Rosuvastatin Calcium	Rosuvastatin Calcium	44	13
Propranolol Hcl	Propranolol Hcl	43	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	42	27
Januvia	Sitagliptin Phosphate	41	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	40	26
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	suppressed
Alendronate Sodium	Alendronate Sodium	38	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	38	26
Lovastatin	Lovastatin	38	suppressed
Lactulose	Lactulose	37	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	37	12
Topiramate	Topiramate	36	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	35	11
Insulin Lispro Kwikpen U-100	Insulin Lispro	35	11
Midodrine Hcl	Midodrine Hcl	35	16
Bumetanide	Bumetanide	34	16
Cephalexin	Cephalexin	34	24
Farxiga	Dapagliflozin Propanediol	34	suppressed
Jardiance	Empagliflozin	34	suppressed
Loperamide	Loperamide Hcl	34	suppressed
Lamotrigine	Lamotrigine	33	suppressed
Metformin Hcl Er	Metformin Hcl	33	11
Brimonidine Tartrate	Brimonidine Tartrate	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	32	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	32	14
Glipizide	Glipizide	31	11
Nifedipine Er	Nifedipine	31	suppressed
Enulose	Lactulose	30	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	14
Albuterol Sulfate	Albuterol Sulfate	27	13
Novolog Flexpen	Insulin Aspart	27	suppressed
Rivastigmine	Rivastigmine	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Ramipril	Ramipril	26	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	26	suppressed
Meloxicam	Meloxicam	25	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Humalog	Insulin Lispro	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	19
Tolterodine Tartrate Er	Tolterodine Tartrate	22	suppressed
Hydroxyurea	Hydroxyurea	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	13
Lurasidone Hcl	Lurasidone Hcl	21	suppressed
Methocarbamol	Methocarbamol	21	17
Sucralfate	Sucralfate	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	12
Triamcinolone Acetonide	Triamcinolone Acetonide	20	12
Amantadine	Amantadine Hcl	19	suppressed
Budesonide	Budesonide	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	13
Tramadol Hcl	Tramadol Hcl	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Carbamazepine Er	Carbamazepine	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Ondansetron Odt	Ondansetron	18	14
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Techlite Pen Needle	Pen Needle, Diabetic	17	suppressed
Amoxicillin	Amoxicillin	16	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Lumigan	Bimatoprost	16	suppressed
Oxcarbazepine	Oxcarbazepine	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Sotalol	Sotalol Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	15	suppressed
Entacapone	Entacapone	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Glucagon Emergency Kit	Glucagon	15	suppressed
Heparin Sodium	Heparin Sodium,porcine	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Liothyronine Sodium	Liothyronine Sodium	15	suppressed
Primidone	Primidone	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Admelog Solostar	Insulin Lispro	14	suppressed
Letrozole	Letrozole	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	14	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Admelog	Insulin Lispro	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Insulin Aspart Flexpen	Insulin Aspart	13	suppressed
Nitroglycerin	Nitroglycerin	13	11
Prednisolone Acetate	Prednisolone Acetate	13	suppressed
Rivastigmine	Rivastigmine Tartrate	13	suppressed
Atenolol	Atenolol	12	suppressed
Caplyta	Lumateperone Tosylate	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Nystatin	Nystatin	12	11
Estradiol	Estradiol	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Lithium Carbonate	Lithium Carbonate	11	suppressed
Mesalamine	Mesalamine	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error